National Mycobacteria Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control (CIb/LIS, pb 22), PO Box 1, 3720 BA Bilthoven, The Netherlands.
Infect Genet Evol. 2010 Jan;10(1):108-14. doi: 10.1016/j.meegid.2009.10.002. Epub 2009 Oct 14.
A total of six polymorphisms were identified by comparing the genomes of the first and the last isolate of a well-characterized transmission chain of Mycobacterium tuberculosis involving five patients over a 12 and a half year period. The six polymorphisms consisted of four single nucleotide changes (SNPs), a tandem repeat polymorphism (TRP) and a previously identified IS6110 transposition event. These polymorphic sites were surveyed in each of the isolates from the five patients in the transmission chain. Surprisingly, five of the six polymorphisms accumulated in a single patient in the transmission chain; this patient had been non-compliant to tuberculosis treatment. This first insight into the tempo and mode of molecular evolution in M. tuberculosis at the patient-to-patient level suggests that the molecular evolution of the pathogen in vivo is characterized by periods of relative genomic stability followed by bursts of mutation. Whatever the mechanism for the accumulation of mutations, this observation may have profound consequences for the application of vaccines and therapeutic drugs, the management and treatment of disease outbreaks of M. tuberculosis, the most important bacterial pathogen of humans.
总共鉴定出了六个多态性,这些多态性是通过比较一个具有良好特征的结核分枝杆菌传播链的第一和最后一个分离株的基因组而得出的,该传播链涉及五个患者,持续了 12 年半的时间。这六个多态性包括四个单核苷酸变化(SNPs)、串联重复多态性(TRP)和以前鉴定的 IS6110 转位事件。在传播链中的五个患者的每个分离株中都检测到了这些多态性位点。令人惊讶的是,六个多态性中有五个在传播链中的一个患者中积累;该患者对结核病治疗不依从。这是首次在患者间水平上对结核分枝杆菌分子进化的时间和模式进行的洞察,表明病原体在体内的分子进化以相对基因组稳定性为特征,随后是突变的爆发。无论积累突变的机制如何,这一观察结果可能对疫苗和治疗药物的应用、结核分枝杆菌疾病爆发的管理和治疗产生深远的影响,结核分枝杆菌是人类最重要的细菌病原体。